A detailed history of Lindbrook Capital, LLC transactions in Scholar Rock Holding Corp stock. As of the latest transaction made, Lindbrook Capital, LLC holds 279 shares of SRRK stock, worth $11,743. This represents 0.0% of its overall portfolio holdings.

Number of Shares
279
Previous 227 22.91%
Holding current value
$11,743
Previous $1,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$7.63 - $9.71 $396 - $504
52 Added 22.91%
279 $2,000
Q2 2024

Jul 31, 2024

SELL
$7.84 - $16.79 $540 - $1,158
-69 Reduced 23.31%
227 $1,000
Q4 2023

Jan 31, 2024

BUY
$6.52 - $20.32 $449 - $1,402
69 Added 30.4%
296 $5,000
Q3 2023

Oct 25, 2023

BUY
$6.02 - $7.76 $252 - $325
42 Added 22.7%
227 $1,000
Q2 2023

Jul 28, 2023

BUY
$5.79 - $9.11 $1,071 - $1,685
185 New
185 $1,000
Q2 2022

Aug 01, 2022

SELL
$4.66 - $13.96 $484 - $1,451
-104 Closed
0 $0
Q1 2022

Apr 21, 2022

BUY
$11.89 - $24.68 $820 - $1,702
69 Added 197.14%
104 $1,000
Q2 2021

Jul 27, 2021

SELL
$26.34 - $46.62 $17,121 - $30,303
-650 Reduced 94.89%
35 $1,000
Q1 2021

Apr 28, 2021

BUY
$45.96 - $68.02 $29,276 - $43,328
637 Added 1327.08%
685 $35,000
Q4 2020

Jan 27, 2021

BUY
$13.72 - $51.57 $178 - $670
13 Added 37.14%
48 $2,000
Q1 2020

Apr 22, 2020

BUY
$9.63 - $17.14 $337 - $599
35 New
35 $0

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.